Investors

2024 Annual Report and Responsible Business Performance Report

Read about our strong performance and pipeline momentum in 2024.

Annual Report 2024 Responsibility Reports

Close Video

Every five minutes, someone's life changes with a gynecological cancer diagnosis.

Myelofibrosis is a rare blood cancer affecting 25,000 in the U.S., causing bone marrow scarring.

Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research.

Our COiMMUNITY Initiative fosters a systematic, collaborative, and approach to boost vaccinations.

As a kid I always enjoyed the simple logic of science and that I could use it to explain the world around me.

Growing up, I loved science and all the prospects that it offered.

We announced our quarter 1 2024 results on Wednesday, May 1st.

Visit our Global site for additional features